Multiple Assemblies exist for SMTL entry 5ntn
Structural states of RORgt: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds; X-RAY DIFFRACTION 1.90 Å

	SMTL ID 5ntn.1 Ligands (5R,10S,13R,14R,17R)-17-((R,E)-7-hydroxy-6-methylhept-5-en-2-yl)-4,4,10,13,14-pentamethyl-1,2,5,6,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-3,7(4H)-dione Polypeptides Nuclear receptor ROR-gamma; Nuclear receptor-interacting protein 1 Oligo-state hetero-1-1-mer
	SMTL ID 5ntn.2 Ligands (5R,10S,13R,14R,17R)-17-((R,E)-7-hydroxy-6-methylhept-5-en-2-yl)-4,4,10,13,14-pentamethyl-1,2,5,6,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-3,7(4H)-dione Polypeptides Nuclear receptor ROR-gamma; Nuclear receptor-interacting protein 1 Oligo-state hetero-1-1-mer
	SMTL ID 5ntn.3 Ligands (5R,10S,13R,14R,17R)-17-((R,E)-7-hydroxy-6-methylhept-5-en-2-yl)-4,4,10,13,14-pentamethyl-1,2,5,6,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-3,7(4H)-dione Polypeptides Nuclear receptor ROR-gamma; Nuclear receptor-interacting protein 1 Oligo-state hetero-1-1-mer
	SMTL ID 5ntn.4 Ligands (5R,10S,13R,14R,17R)-17-((R,E)-7-hydroxy-6-methylhept-5-en-2-yl)-4,4,10,13,14-pentamethyl-1,2,5,6,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-3,7(4H)-dione Polypeptides Nuclear receptor ROR-gamma; Nuclear receptor-interacting protein 1 Oligo-state hetero-1-1-mer